Brain.fm - Your Minds Next Frontier (W // DOUBLE YOU x MYTHAPHI VISUALS #003)

Brain.fm - Your Minds Next Frontier (W // DOUBLE YOU x MYTHAPHI VISUALS #002)

Brain.fm - Your Minds Next Frontier (W // DOUBLE YOU x MYTHAPHI VISUALS #001)

Graham Hancock: The history of altered states of consciousness

Dennis McKenna "The Brotherhood Of The Screaming Abyss" Reading [Part 2]

Dennis McKenna "The Brotherhood Of The Screaming Abyss" Reading [Part 1]

DENNIS MCKENNA & THE BROTHERHOOD OF THE SCREAMING ABYSS

ORIGIN OF CONSCIOUSNESS TOUR 2012

DMTrmx TEASER

Movie excerpt: DMT research volunteers describe their experience

Ralph Metzner: My first ayahuasca experience

Ralph Metzner: Shamans who snuffed tryptamines

Ralph Metzner: Research and Harvard days

Ralph Metzner: Integrating these substances into our culture

Ralph Metzner: I wasn't advocating drugs just sharing my discoveries

Ralph Metzner: Preparation beforehand and Integration afterwards

Ralph Metzner: The DMT toad

Ralph Metzner: Effects of tryptamines

Ralph Metzner: Differences between Shamanistic and Western views (Part 2)

Ralph Metzner: Differences between Shamanic and Western views (Part 1)

Ralph Metzner: Death

Ralph Metzner: Ayahuasca

Ralph Metzner: When I first heard of DMT

Ralph Metzner: My experience of injecting DMT

Ralph Metzner: Name and Occupation

Steven Barker: There still is a need in the human to have some kind of closure

Steven Barker: There may be a role for DMT explaining any number of hallucinatory phenomena

Steven Barker: There is an endogenous hallucinogen neuronal system

Steven Barker: The model we were using in the lab was an animal model

Steven Barker: The lung tissue contains a large amount of enzyme capable of methylating

Steven Barker: The counterculture in this country

Steven Barker: The concentration of DMT and other molecules found in humans

Steven Barker: Skeptical eye toward transmethylation hypothesis in general

Steven Barker: Schizophrenia may be related as a lung disease

Steven Barker: Regulating respiratory function and compound synthesis and release

Steven Barker: Redo all of the studies on endogenous hallucinogens

Steven Barker: Presence of entities in altered states, are these real phenomenon

Steven Barker: Ourselves as intelligent is a matter of semantics

Steven Barker: Original hypothesis was that these compounds would be schizo toxins

Steven Barker: Neurotransmitters

Steven Barker: Name, Occupation, Background

Steven Barker: Metabolism of DMT compound created another group of compounds

Steven Barker: Melatonin

Steven Barker: Laymen's terms of tryptophan and melotonin

Steven Barker: I think DMT is 17 to 18 times less potent than LSD

Steven Barker: How I came about to where I am today career-wise

Steven Barker: DMT is 1:10 as potent as LSD

Steven Barker: DMT has been found in the nanogram levels

Robert Gable: What was intriguing about DMT

Robert Gable: What should be looked at to study ayahuasca users

Robert Gable: We need a new model for psychoactive drugs

Robert Gable: Thoughts on endogenous DMT

Robert Gable: There isn't much data on ayahuasca, but habitual users seem mostly fine

Robert Gable: The low dose of endogenous DMT may inoculate us to be able to take higher doses

Robert Gable: The FDA doesn't have any classification for nonmedical drugs

Robert Gable: Study of psychedelics shouldn't be so much about the answers

Robert Gable: Religious schools need to study these drugs

Robert Gable: Religious practitioners should be making empirical studies

Robert Gable: Psychology and shamanism could both help make drugs safe

Robert Gable: People's demeanors after DMT seem to indicate a spiritual experience